Bristol Will Buy Diabetes Drug Maker

Bristol-Myers Squibb said it will buy diabetes drug maker Amylin in a $7 billion deal that will intensify the competition to treat the growing number of people afflicted with the disease.

BING NEWS:
  • Bristol-Myers Top NASH Contenders
    Right now they have 8 Indications with Opdivo, or in combination with their lead drug, and have an additional 8 more indications ... To get in the game they are going to need to buy or license a technology that is in Phase 2 and has already shown some ...
    06/12/2018 - 7:49 am | View Link
  • AstraZeneca to buy Bristol out of diabetes venture for up to $4.1 billion
    LONDON (Reuters) - AstraZeneca has agreed to buy Bristol-Myers Squibb’s stake in the ... received a boost when an advisory panel to the U.S. Food and Drug Administration endorsed its new diabetes pill dapagliflozin.
    12/18/2013 - 11:00 am | View Link
  • UPDATE 2-AstraZeneca to buy Bristol out of diabetes venture for up to $4.1 bln
    LONDON, Dec 19 (Reuters) - AstraZeneca has agreed to buy Bristol-Myers Squibb’s stake in ... a boost when an advisory panel to the U.S. Food and Drug Administration endorsed its new diabetes pill dapagliflozin. (Editing by Greg Mahlich) Our Standards ...
    12/18/2013 - 11:00 am | View Link
  • Bristol-Myers Squibb starts Amylin tender offer
    NEW YORK (AP) -- Bristol-Myers Squibb Co. is starting a tender offer to buy all of the outstanding shares of diabetes drug maker Amylin Pharmaceuticals Inc. Late last month, Bristol-Myers Squibb said that it planned to buy San Diego-based Amylin for ...
    07/10/2012 - 2:29 am | View Link
  • Bristol-Myers to buy diabetes drug maker for $5B
    NEW YORK (AP) -- Bristol-Myers Squibb Co. agreed to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash, heating up the competition among drugmakers to develop diabetes treatments. After the deal is complete, Bristol-Myers will ...
    07/2/2012 - 1:21 pm | View Link
  • More
BING SEARCH:
  • Bristol-Myers off on profit, diabetes drug
    Bristol-Myers off on profit, diabetes drug ... Bristol-Myers said that the Food and Drug Administration has asked for additional information on the drug's ...
    06/14/2018 - 4:16 am | View Website
  • Bristol-Myers Squibb (BMS)
    In 2012, in the culmination of a series of deals over the years to buy or partner with other drug companies, Bristol-Myers Squibb announced the acquisition of Amylin Pharmaceuticals, a biopharmaceutical company focused on research, development and commercialization of Type 2 diabetes drugs, including the troubled Byetta and Bydureon.
    04/17/2018 - 7:58 pm | View Website
  • BMS Sells Diabetes Business to AstraZeneca for Up to $4B ...
    Bristol-Myers Squibb (BMS) said it will sell its global diabetes business to its collaboration partner AstraZeneca (AZ), in a deal that could net the pharma giant more than $4 billion—little more than a month after BMS said it would exit broad-based discovery research in diabetes as part of an announced R&D restructuring.
    12/18/2013 - 6:58 pm | View Website
  • Bristol-Myers to buy diabetes drug maker for $5B
    Bristol-Myers Squibb Co. agreed to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash, heating up the competition among drugmakers to develop diabetes treatments.After the deal ...
    07/2/2012 - 7:18 pm | View Website
  • Bristol-Myers to buy diabetes drug maker for $5B
    (AP) — Drug maker Bristol-Myers Squibb Co. says it agreed to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash. Bristol-Myers says it will pay $31 per share for Amylin in a cash tender offer.
    07/1/2012 - 1:36 pm | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News